Aaron Boster

What are you doing?

Like, and I learned to just let all the thoughts go.

And I'll spend five minutes, 10 minutes just breathing.

And it's transformative.

It's the one of the best parts of my day, believe it or not.

Now, the fifth thing is to take the most effective DMT possible and make sure it's working.

And I want to refer the most effective DMT that you're comfortable taking and make sure it's working.

It's a disease-modifying therapy.

Got it.

You're like, oh, Aaron, that's a very – no.

I was like, holy shit, really?

Yeah.

No, what I mean is I want you on the most effective disease-modifying therapy that you're comfortable taking.

Okay.

And I want to make sure that it's working.

There are a couple things going on right now in the MS space which really have me jazzed.

Amongst the biggest are some of the developments in the brutine tyrosine kinase or BTK inhibitor space.

We studied one BTK inhibitor called tolibrutinib.

in a non-relapsing secondary progressive MS trial called the Hercules trial.

And I'm very proud that at the Boster Center, we enrolled a bunch of patients into this trial.